27.09.2010 • News

Lanxess Announces Management Changes in 3 Business Units

There will be a change in management at three of the 13 business units of specialty chemicals company Lanxess. Dr. Hans-Georg Schmitt, head of the Basic Chemicals business unit (BAC), will retire as of Jan. 1. Schmitt has been in charge of Basic Chemicals since the formation of Lanxess.

Dr. Hubert Fink, currently head of the Semi-Crystalline Products business unit (SCP), will succeed Schmitt at the Basic Chemicals business unit at the turn of the year.

The successor to Dr. Fink as head of the SCP business unit is Dr. Michael Zobel, MBA. He will assume his new role as of Oct. 15. He is currently responsible for the Lanxess Ion Exchange Resins business unit (ION).

Dr. Zobel's position as head of ION will be taken over by Jean-Marc Vesselle at the same time. Vesselle is currently responsible for the global product management and strategic development of the business unit.

Company

Logo:

LANXESS Deutschland GmbH

Kennedyplatz 1
50569 Köln
Germany

Company contact







Virtual Event

Outsourced Biomanufacturing
Strategic Outsourcing in Biopharmaceuticals

Outsourced Biomanufacturing

April 22, 2026 | Join biopharma professionals, CDMO leaders, and supply chain innovators for a virtual event exploring the future of outsourced biomanufacturing.

Expert Insights

ADCs for Precision Cancer Therapy
Comprehensive Insights into Antibody–Drug Conjugates

ADCs for Precision Cancer Therapy

Explore how antibody-drug conjugates are reshaping precision cancer therapy and discover what it takes to successfully develop, manufacture, and scale these complex biologics.

most read